Sign Out
The safety of this medicinal product for use in human pregnancy has not been established by well con trolled studies in pregnant women. Reproduction studies have been performed in mice and rats at doses of up to 10 times the human dose and these studies have revealed no evidence of impaired fertility or harm to the fetus due to amoxicillin.
''Moxilen'' may be used in pregnancy when the potential benefits outweigh the potential risks associated with treatment.
''Moxilen'' may be given during lactation. With the exception of the risk of sensitisation associated with the excretion of trace quantities of amoxicillin in breast milk, there are no known detrimental
effects for the breast-fed infant.
